| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
E. Rand Sutherland, M.D.
Also a director
Chief Executive Officer
Title from the Form 4 dated Sep 16, 2026
|
56 | Not stated | Not stated | $4,302,100 | |
|
Michael Paul Gray
CFO and COO
Title from the Form 4 dated Sep 16, 2026
|
55 | Not stated | 2024 | $1,993,437 | |
|
Adam Houghton
Chief Business Officer
|
55 |
Since 2021
5 years
|
Not stated | Not reported | |
|
Allison Ambrose
Sr. Vice President, General Counsel and Secretary
|
41 | Not stated | Not stated | Not reported | |
|
Aaron Deykin
Chief Medical Officer and Head of Research and Development
|
60 |
Since 2022
4 years
|
Not stated | $1,830,916 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
The proxy filed Apr 16, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...